Parents of teens with severe acne should expect two clinic-based pregnancy tests before isotretinoin can start in 2026. Pretreatment tests must still occur in a medical setting, even after new rules allow at-home tests during treatment.
iPLEDGE is the restricted safety program for isotretinoin. It requires prescriber and pharmacy certification and enrollment of every patient. The program exists because isotretinoin can cause severe birth defects and embryo-fetal toxicity.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Why is testing required before treatment?
- What happens at the two pretreatment visits?
- Can our family use at-home tests in 2026?
- What if we miss the pickup window?
Why is testing required before treatment?
Isotretinoin is FDA-indicated only for severe recalcitrant nodular acne in nonpregnant patients age 12 and older. According to FDA labeling, eligible patients have multiple 5-mm inflammatory nodules that did not respond to conventional therapy including systemic antibiotics FDA isotretinoin labeling. Because of embryo-fetal toxicity, the drug is available only through the iPLEDGE shared-system REMS. Every patient must enroll, and prescribers and pharmacies must be certified.
For a teen who can become pregnant, pregnancy testing is a mandatory safety step, not an optional clinic policy. Parents should expect enrollment paperwork, contraception counseling, and lab visits before any prescription. The process takes at least one month because the two pretreatment tests are spaced apart. Planning for school absences and transportation helps.
What happens at the two pretreatment visits?
Patients who can become pregnant must have two negative pregnancy tests before starting isotretinoin. According to the FDA advisory briefing materials, the second test is confirmatory and occurs after 30 days using two contraception forms or abstinence plus an online comprehension test before authorization FDA briefing document.
The practical sequence usually looks like this: Unless continuously abstinent, the teen must use two effective contraception methods together. That requirement covers one month before, throughout treatment, and for one month after isotretinoin. If pregnancy occurs, the teen must stop the drug and see an obstetrician-gynecologist experienced in reproductive toxicity.
- first clinic pregnancy test and enrollment, with a contraception plan
- one month of two simultaneous effective contraception methods or continuous abstinence
- second clinic pregnancy test plus the online comprehension check for system authorization
Can our family use at-home tests in 2026?
No, not for the pretreatment phase. According to the National Community Pharmacists Association summary of the approval, FDA approved iPLEDGE modifications on Feb. 9, 2026, effective Aug. 9, 2026 NCPA report on the FDA approval. Under that change, prescribers may allow at-home pregnancy testing during and after treatment. Pretreatment tests must still occur in a medical setting.
At-home testing also requires prescriber processes to minimize fetal-exposure risk. Until Aug. 9, 2026, FDA enforcement discretion from Oct. 2023 continues. Parents should therefore expect clinic-based pretreatment labs for a teen in 2026. Ask the dermatology office where labs are done and how results enter iPLEDGE.
What if we miss the pickup window?
FDA removed the 19-day lockout. A patient who missed the 7-day prescription pickup window can repeat the pregnancy test immediately without added waiting. Treatment can then move forward sooner when the repeat test is negative and authorization is complete. If the first isotretinoin dose was never taken, the repeat test must be in a medical setting.
Parents should keep the original clinic lab order and contact the prescriber quickly. Do not start leftover capsules from another month. During treatment, patients who can become pregnant need a negative pregnancy test before each monthly prescription. Prescriptions are limited to a 30-day supply, with monthly prescriber visits and iPLEDGE authorization. Keep contraception, appointments, testing, and pickup on the same monthly schedule.
You Might Also Like
- Pretreatment Pregnancy Testing Under iPLEDGE in 2026: Access and Prescription-Window Questions for Parents of Teens With Severe Acne
- Planned Home Pregnancy Testing Under the 2026 iPLEDGE Changes: Pregnancy Testing Questions for Parents of Teens With Severe Acne
- Pediatric Acne and Rosacea at the 2026 AAD Annual Meeting: Treatment-Selection Questions for Parents of Teens With Acne